Article
Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection
23 Jun 2018
Abstract excerpt
Cancer is characterized by Darwinian evolution and is a primary cause of mortality and morbidity around the globe. Over the preceding decade, the treatment of cancer has been markedly improved by many targeted therapies, but these treatments have given birth to new challenges and issues. Clonal evolution and tumor heterogeneity present a significant challenge in designing cancer therapies. Fortunately, these...
Topics
Join the communities discussing this publication.